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Received 21 April 1993/Returned for modification 8 June 1993/Accepted 29 June 1993
Using oligonucleotide probes which have previously been shown to be specific for the ospC gene found in the
Lyme disease spirochete species Borrelia burgdorferi, B. garinii, and group VS461, we detected an ospC
homolog in other Borrelia species including B. coriaceae, B. hermsii, B. anserina, B. turicatae, and B. parkeri.
In contrast to the Lyme disease spirochetes, which carry the ospC gene on a 26-kb circular plasmid, we mapped
the gene in other Borrelia species to linear plasmids which varied in size among the isolates tested. Some isolates
carry multiple copies of the gene residing on linear plasmids of different sizes. The analyses conducted here also
demonstrate that these Borrelia species contain a linear chromosome. Northern (RNA) blot analyses
demonstrated that the gene is transcriptionally expressed in all species examined. High levels of transcriptional
expression were observed in some B. hermsii isolates. Transcriptional start site analyses revealed that the length
of the untranslated leader sequence was identical to that observed in the Lyme disease spirochete species. By
Western blotting (immunoblotting) with antiserum (polyclonal) raised against the OspC protein of B.
burgdorferi, we detected an immunoreactive protein of the same molecular weight as the OspC found in Lyme
disease spirochete species. The results presented here demonstrate the presence of a protein that is genetically
and antigenically related to OspC which is expressed in all species of the genus Borrelia tested.

Four outer surface proteins, OspA, OspB (6), OspC (12),
and OspD (23), have been described for Lyme disease
bacteria. OspA and OspB have been found to vary in
molecular weight (5, 8, 13), isoelectric point (20), immunoreactivity (1, 5, 11, 13, 20, 35, 36), and sequence (9, 11, 13,
20, 27) among the three spirochete species, Borrelia burgdorferi, B. garinii, and group VS461 (1, 7, 16-18, 21, 34),
associated with Lyme disease. OspA and -B are cotranscribed (6) and carried on a linear plasmid (3, 4) of 50 kb in B.
burgdorferi, 55 kb in B. garinii, and 56 kb in group VS461
isolates (29). The ospD gene has been mapped in some
isolates to a 38-kb linear plasmid (23). Recently, we have
mapped the ospC gene to a 26-kb circular plasmid in the
Lyme disease spirochete species (22). ospC represents the
first Borrelia gene to be mapped to a circular plasmid.
The cellular function of OspC and its potential contributions to the pathogenicity of the Lyme disease spirochetes
are unknown. The immunological response of patients who
had Lyme disease to this protein has been suggested to be
more common in European than in North American patients
(12). The immune response to OspC is primarily an immunoglobulin M response (38). Since the host immune response
to OspC occurs early in the infection, it has been suggested
that this protein may prove highly useful as an antigen for the
serodiagnosis of Lyme disease (12).
In this report, we demonstrate that a protein with properties similar to those of OspC from Lyme disease spirochete
species is carried by other species of the genus Borrelia
including the relapsing fever spirochetes, B. hennsii, B.
parkeri, and B. turicatae; the putative agent of epizootic
bovine abortion, B. coriaceae (15); and B. anserina. We
refer to this protein as an OspC homolog. In contrast to
Lyme disease spirochetes, the ospC gene in other Borrelia
species resides on linear plasmids. The transcriptional ex*
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pression of this gene is most pronounced in some B. hermsii
isolates. By primer extension analysis, we have found that
the ospC 5' untranslated leader sequence observed in the
species investigated here has a length equivalent to that of
the untranslated leader sequence of transcripts derived from
the P1 ospC promoter in the Lyme disease spirochetes (22).
Western blot (immunoblot) analysis with a polyclonal antiOspC antibody provided further evidence for the expression
of this gene and for the conservative nature of this protein
among Borrelia species. The detection of this gene and its
gene product in Borrelia species not associated with Lyme
disease suggests that careful consideration must be given to
the suggested use of OspC as an antigen for the serodiagnosis of Lyme disease (12, 25a).

MATERIALS AND METHODS

Bacterial isolates and cultivation. All isolates were cultivated in BSKII medium (2) at 34°C and are described in
Table 1. All isolates investigated in this study have been
passaged in the laboratory over an extended period of time.
Hence, while the exact passage number is not known, they
are considered to be of high passage.
DNA and RNA isolation. After pelleting of the cells by
centrifugation, the cells were washed three times with phosphate-buffered saline (PBS). DNA was isolated as previously
described (5) except that the lysozyme treatment was omitted from the protocol. RNA was isolated as described by
Selden (32) except that the lysozyme treatment step was
omitted. Briefly, the cells were resuspended in lysis buffer
(10 mM Tris-HCl [pH 8.01, 10 mM NaCl, 1 mM Na citrate,
1.5% sodium dodecyl sulfate [SDS]), incubated for 5 min at
370C, and then chilled on ice. Saturated NaCl (0.5 volume)
was added, and incubation on ice was continued for 10 min.
Each sample was then microcentrifuged for 10 min at high
speed; ethanol precipitation of the supernatant followed.
The resulting pellets were resuspended in H20, treated with
2577
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TABLE 1. Borrelia species and isolates used in this study
Species and isolate

Origin

Geographic origin

Borrelia hennsii HS1
Ornithodoros hennsii Washington State
Borrelia hermsii MAN-1 Human blood
California
Borrelia hermsii YOR-1
Human blood
California
Human blood
Borrelia hermsii FRO
Washington State
Borrelia turicatae
Ornithodoros turicata Unknown
Borrelia turicatae 91E135 Omithodoros turicata Texas
Borrelia parkeri
Omithodoros parkeri
Unknown
Borrelia coriaceae C053 Ornithodoros coriaceus California
Borrelia anserina BA-2
Unknown
Unknown
Borrelia garinii VS102
Switzerland
Lxodes ricinus
Borrelia burgdorferi
California
Lodes pacificus
DN127 c19/2a
a This is a cloned isolate from DN127. All isolates are high passage.

RQ1-DNase (Promega Biotec) at 37°C for 0.5 h, extracted
with phenol-chloroform, ethanol precipitated, and resus-

pended in H20. All reagents used in RNA isolation were
either treated with diethylpyrocarbonate or prepared with
diethylpyrocarbonate-treated H20.
Transcriptional start site mapping. The length of the 5'
untranslated leader sequence of the ospC transcript was
determined by reverse transcriptase primer extension analysis (22). The identity of the transcriptional start site was
confirmed with two different extension primers, pC13 (5'GTC-AIT-AAT-ATC-GCA-CTT-AAT-G) and pC52 (5'CCC-TGA-ATT-ATIT-ACA-AGA). The primers and methods have been previously described (22).
Northern (RNA) blot analysis. Total cellular RNA was
fractionated in 1.2% agarose-formaldehyde gels as previously described (33). Following electrophoresis, the gels
were soaked for 10 min in diethylpyrocarbonate-treated H20
and then vacuum blotted onto GeneScreen membranes (DuPont) with the VacuGene system (Pharmacia) as instructed
by the manufacturer, with some modifications. The H20
washing step was increased to 10 min. Either 2 or 20 ,ug of
total cellular RNA was loaded per lane, as indicated in the
legend to Fig. 3. Blots were probed at 37°C with the pC13
5'-end-labeled oligonucleotide probe as described above
with hybridization solutions previously described (17). Oligonucleotides were radiolabeled by standard methods. Blots
were washed

twice at 370C with 2x SSC-0.1% SDS for 10

min each (lx SSC is 150 mM NaCl and 15 mM Na citrate,
pH 7.0) and once for 1 h at 37°C with O.lx SSC-0.2% SDS.
The RNA was fixed on the membranes via UV cross-linking
with a Stratalinker (Stratagene) as instructed by the manufacturer.
TAFE and Southern blotting. DNA in agarose plugs was
as described by Ferdows and Barbour (10) with
modifications described elsewhere (29). DNA was fractionated in 1% agarose gels by transverse alternating field gel
electrophoresis (TAFE) in 0.25 x TBE (22 mM Tris, 22 mM
borate, 0.5 mM EDTA) with a GeneLine II system (Beckman) at 13°C. Electrophoresis was at 350 mA with pulse
times of 1 s for 1 h, 2 s for 2 h, 3 s for 2 h, 4 s for 2 h, 5 s for
2 h, 6 s for 2 h, 7 s for 2 h, 8 s for 2 h, 15 s for 1 h, 60 s for
2 h, 75 s for 3 h, 90 s for 3 h, 105 s for 3 h, 120 s for 2 h,
and 150 s for 1 h. Molecular weight standards were Low
Range PFE Markers (New England Biolabs) and Saccharomyces cerevisiae YNN 295 chromosomal DNA (Beckman).
Plasmid sizes were determined with an NA2 nucleic acid

prepared

analyzer (Bethesda Research Laboratories). We have previously postulated that size determination of DNA fraction-

ated in TAFE gels is slightly greater than the actual size (29);
hence, the sizes presented are approximate.
For Southern blot analysis, DNA fractionated by TAFE
was transferred onto Hybond-N membranes (Amersham) by
vacuum blotting as instructed by the manufacturer, with
some modifications. The depurination and denaturation
steps were extended to 10 min each. After transfer, the DNA
was fixed on the membrane and hybridized with the 5'-endlabeled pC13 probe as described above.
Two-dimensional gel electrophoresis. The conformation of
the DNA molecules carrying the ospC gene was determined
by two-dimensional gel electrophoresis as previously described (22, 28). Briefly, isolated DNA was electrophoresed
in a 0.35% gel in the first dimension for 18 h at 0.4 V/cm in
standard 1 x TAE buffer. The gel was then soaked in 15 ,uM
chloroquine in 1 x TAE, rotated 900 (relative to the direction
of electrophoresis in the first dimension), and electrophoresed for 18 h at 0.4 V/cm. Prior to ethidium bromide staining,
the chloroquine was removed from the gel by soaking in
H20. The fractionated DNA was transferred onto GeneScreen membranes for hybridization analysis with the pC13
oligonucleotide probe as described above.
Protein profile and Western blot analysis. Cells were pelleted by centrifugation, washed twice with PBS, and resuspended in PBS, and the optical density was determined at
A540. Cells were resuspended at 1 optical density unit per 100
,ul in solubilizing solution (14). The solubilized proteins (20
,ul) were then fractionated by electrophoresis through SDS12.5% polyacrylamide gels at 50 mA until the dye front
reached the bottom of the gel. The gels used for protein
profile analysis were then stained with Coomassie brilliant
blue (R-250) and destained by standard procedures. For
Western blotting, one gel was transferred onto a nitrocellulose membrane by electroblotting as previously described
(31). The blot was screened with a monospecific rabbit
polyclonal antiserum raised against gel-purified OspC from
the B. burgdorferi isolate Sh-2-82 (30) at a 1:500 dilution as
previously described (31).

RESULTS
Detection and mapping of ospC gene homolog. Undigested
DNA was fractionated by TAFE and subjected to Southern
blot analysis with the pC13 oligonucleotide probe. Previously, we have shown that the pC13 target sequence is
conserved among the three species of Lyme disease spirochetes as inferred from the ability of the probe to hybridize
with the ospC gene in all isolates tested (22). Southern
blotting demonstrated that a sequence complementary to the
pC13 probe occurred in the spirochete species B. hermsii, B.
parkeri, B. turicatae, and B. coriaceae (Fig. 1). We were
able to detect only weak hybridization with B. anserina with
the pC13 probe. However, as discussed below, we were able
to detect ospC transcript in B. anserina with the same probe.
With the exception of the B. garinii positive control, the
ospC-carrying DNA fragments migrated ahead of the chromosomal DNA, suggesting that the gene(s) is carried on
plasmids (Fig. 1). These plasmids appear to be linear in
conformation on the basis of their migration in the TAFE
gels. Circular plasmids have been demonstrated to migrate
anomalously, near the chromosome, in TAFE gels (10, 22).
The 26-kb circular plasmid which carries the ospC gene in
Lyme disease spirochetes (22) migrates with an apparent
size of 1.5 megabases, as shown in Fig. 1 for the B. garinii
isolate G1. Southern blotting of the TAFE-fractionated DNA
demonstrated the presence of multiple copies of the gene in
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FIG. 1. DNA fractionation by TAFE and subsequent Southern
blot analysis. The DNA from several Borrelia species and isolates
was fractionated in TAFE gels (A), blotted to hybridization membranes, and probed with radiolabeled pC13 oligonucleotide (B) as
described in the text. The location of the linear chromosome is
indicated by the letter C. Molecular size markers (in kilobases) are
indicated between panels.

some Borrelia species. In B. hernsii isolates, the sizes of the
hybridizing molecules were 62 and 37 kb in isolate HS1 and
62 and 39 kb in isolate MAN-1. In the B. hermsii YOR-1
isolate, two bands of 85 and 58 kb were seen (data not
shown). Variability in the size of the plasmids carrying ospC
was also found among B. tuicatae isolates. While four
hybridizing bands (62, 58, 54, and 52 kb) were observed in
the 91E135 isolate, only one was observed in a second B.
tuicatae isolate (in the text, we refer to this isolate as the
RML isolate to differentiate it from isolate 91E135) of
approximately 52 kb. B. parkeri and B. coriaceae exhibited
one hybridizing band each of 80 and 45 kb, respectively.
Consistent with that reported for the Lyme disease spirochetes (10, 29), the Borrelia species investigated here were
also found to possess a linear chromosome (Fig. 1).
Two-dimensional gel electrophoresis. To confirm further
that the ospC gene was carried on linear plasmids, we
performed two-dimensional gel electrophoresis. By this approach, linear plasmids can be differentiated from circular
plasmids (22, 28). Upon electrophoresis in the second dimension in the presence of chloroquine, some bands were found
to migrate with retarded mobility, demonstrating the presence of circular plasmids. The two-dimensional ethidium
bromide-stained gels and the subsequent Southern blots of
two representative species (B. hermsu and B. turicatae) are
presented in Fig. 2. The locations of the circular plasmids are
indicated by arrowheads, and the locations of the hybridizing linear plasmids are indicated by arrows. As judged by

FIRST
DIMENSION

-

SECOND
DIMENSION
FIG. 2. DNA fractionation by two-dimensional gel electrophoresis and subsequent Southern blot analysis. Isolated DNA from B.
hemsii HS1 and B. turicatae was fractionated by two-dimensional
gel electrophoresis, blotted to hybridization membranes, and probed
with radiolabeled pC13 oligonucleotide as described in the text.
Prior to electrophoresis in the second dimension, the gel was soaked
in 15 I1M chloroquine in lx TAE buffer. The direction of electrophoresis in each dimension is indicated in the figure. The panels on
the left depict the ethidium bromide-stained gels, and the subsequent Southern blots are depicted on the right. The locations of the
loading wells are indicated by an "o." The ethidium bromidestained bands which correspond with the hybridization-positive
bands are indicated by arrows, and the locations of circular plasmids
are indicated by arrowheads.

ethidium bromide staining, the copy number and presence of
the circular plasmids varied among species. Southern blotting with the pC13 probe revealed that the migration of the
hybridizing bands was unaffected by chloroquine treatment,
therefore confirming their linear conformation (Fig. 2). To
further confirm that the plasmids carrying the ospC homolog
were linear in conformation, we excised the two hybridizing
bands of the B. hermsii MAN-1 isolate from a TAFE gel and
examined them by transmission electron microscopy (data
not shown). By this approach, the linear conformation of
these plasmids was clearly elucidated.
Northern blot analyses. When the pC13 probe was used to
screen Northern blots, transcript was detected in all Borrelia
species tested (B. hermsii, B. parkeri, B. turicatae, B.
anserina, B. coriaceae, B. burgdorferi, B. garinii, and group
VS461). The ospC transcript in B. hermsii, B. turicatae, and
B. anserina was approximately 730 bases in length (Fig. 3),
the same size as that observed in B. burgdorferi, B. garinii,
and group VS461 isolates (22). However, the transcript
detected in B. coriaceae and B. parkeri was approximately
1,150 nucleotides in length. ospC transcript was not detected
in Leptospira interrogans serovar hardjo or in a recently
characterized spirochete isolate, CT11616 (24) (ATCC
43811) (data not shown). The relative autoradiographic signal intensity varied widely among the species and isolates of
a given species (Fig. 3), implying different levels of transcription of this gene. Increasing the stringency of hybridization
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FIG. 3. Northern blot analysis of the ospC transcript. Total
cellular RNA was fractionated in 1.2% agarose-formaldehyde gels,
vacuum blotted to hybridization membranes, and probed with the
pC13 oligonucleotide as described in the text. All samples were
electrophoresed in the same gel. A total of 2 ,ug of RNA was loaded
for each isolate in panel A while 10 ,ug of RNA was loaded for B.
garinii VS102 and 20 ,ug was loaded for all remaining Borrelia
isolates in panel B. Prior to exposure of the blot to film, the portion
of the blot carrying the B. hermsii isolates MAN-1 and YOR-1 was
cut off and exposed to film separately. Panel A was exposed for 2 h
while panel B was exposed for 28 h. The positions of the 16S and 23S
rRNAs are indicated between the panels.

had no effect on the relative autoradiographic signal observed among species, and since signal intensity did not
appear to vary significantly among isolates in Southern blots
(with the exception of B. anserina), the difference in signal in
the Northern blots most likely reflects differences in transcript level rather than variability in the probe target sequence. The B. hennsii isolates MAN-1 and YOR-1 produced significantly more ospC transcript than was observed
in B. hermsii HS1 or in other Borrelia species. To obtain a
balanced autoradiograph, only 2 ,ug of total RNA was loaded
per lane for these isolates (1/10 the amount loaded for other
isolates). In addition, to achieve similar signal intensity the
blot in panel A of Fig. 3 was exposed to film for only 2 h
while the blot in panel B required a 28-h exposure.
Transcriptional start site mapping. All Borrelia isolates
tested were found to exhibit primer extension products of
the same length. With the pC13 primer, a major extension
product of 32 nucleotides was observed in most isolates (Fig.
4). In B. anserina, a second minor extension product of 35
nucleotides was also observed (the extension product
lengths referred to in this, and all subsequent discussions, do
not include the length of the primer). To verify further that
the transcripts detected were derived from the ospC gene, a
second primer, pC52, was used in primer extension reactions. This primer yielded a major extension product of 71
nucleotides and a second minor product of 74 nucleotides
(Fig. 4). Hence, the results obtained with this primer are
consistent with that observed with the pC13 primer in that
both primers indicate a 5' untranslated leader sequence of 20
nucleotides in length. We note, however, that primer extension products were not observed for all isolates with both
primers (Fig. 4), indicating some degree of sequence vari-

35 -*
32-*
-Ib
w.
*.-w

pC13 primer

pC52 primer

FIG. 4. ospC transcriptional start site analyses. The length of the
5' untranslated leader sequence and, hence, the transcriptional start
site were determined by the primer extension method as described
in the text. The pC13 and pC52 probes were used as primers in the
left and right panels, respectively. With prolonged exposure, extension products are also visible when the pC52 primer is used for all B.
hermsii isolates but not for B. coriaceae. The numbers indicated on
both the left and the right of the figure indicate the length of the
extension products (excluding the length of the nucleotide) for each

primer.

ability in the 5' region of the gene. Nonetheless, the size of
the extension products observed in the Borrelia species not
associated with Lyme disease is consistent with that observed for the ospC 5' untranslated leader sequence in B.
garinii, B. burgdorferi, and group VS461 isolates, which is
also approximately 20 nucleotides in length (22).
Western blot analyses. Analysis of protein profiles revealed
that in several species a protein with a molecular weight
similar to that of the OspC protein of Lyme disease spirochetes was expressed (Fig. 5A). By Western blotting, with a
polyclonal antibody preparation generated against gel-purified B. burgdorferi OspC, an immunoreactive protein analogous to OspC was observed in some isolates (Fig. SB). That
this polyclonal antibody preparation specifically recognizes
OspC has also been demonstrated by Norris et al. (23). B.
hermsii isolates FRO and MAN-1, B. parkeni, and B. anserina each possessed proteins of approximately 24 kDa that
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FIG. 5. Protein profile (A) and Western blot analysis (B) using an OspC polyclonal antibody. All methods were as described in the text.
The B. hennsii FRO isolate, which was not subjected to the other analyses described in this report, is included here for additional information.
The B. burgdorferi isolate was included as a positive control. The location of OspC is indicated by arrows.

reacted with the sera. In the B. hernsii isolate YOR-1, an
immunoreactive protein of approximately 26 kDa was observed. Reactivity with a protein of approximately 14 kDa
was observed in all species including the B. burgdorferi
positive control. The identity of this protein is currently
unknown.
DISCUSSION
In this study, we have identified and mapped a gene in B.
henmsii, B. turicatae, B. parkeri, B. coriaceae, and B.
anserina which codes for a protein genetically related and
antigenically similar to OspC found in Lyme disease spirochetes. Although the overall degree of sequence relatedness
between the ospC homolog detected here and the ospC gene
of Lyme disease spirochetes is not known, we will refer to
the homolog simply as ospC throughout this discussion. In
contrast to the Lyme disease spirochetes, which carry a
single copy of the ospC gene on a circular plasmid (22), the
gene was found to be carried on one or more linear plasmids
which vary in size among the Borrelia species not associated
with Lyme disease. The oligonucleotide probes used in this
study were designed on the basis of the sequence reported
for the ospC gene of the group VS461 isolate PKo (12). When
data bases were searched for sequences complementary to
these probes, no genes other than ospC were found. How-

ever, the probes did share some similarity with the vmp
genes of B. hermsii, which are carried on linear plasmids
(26). The linear conformation of the plasmids carrying the
ospC homolog genes was confirmed by three independent
approaches including TAFE analysis, two-dimensional chloroquine gel electrophoresis, and transmission electron microscopy. It is interesting to note that the presence of this
gene on either a linear or a circular plasmid is coincident
with the evolutionary lines of divergence among Borrelia
species (17). 16S rRNA phylogenetic analyses have demonstrated a deep branching between those Borrelia species
carried by hard-bodied ticks (B. burgdorferi, B. garinii, and
group VS461) and those carried by soft-bodied ticks (B.
hermsii, B. anserina, B. coriaceae [17], B. parkeri, and B.
turicatae [19]). All Borrelia species that we have analyzed
which are carried by soft-bodied ticks carry the ospC gene
on one or more linear plasmids, while species carried by
hard-bodied ticks carry the gene on a single circular plasmid
(22).
Multiple copies of the ospC gene were found to occur in
some species. In a previous study of 30 Lyme disease
spirochete isolates, all were found to possess one copy of the
gene by restriction fragment length analysis (22). B. hermsii
isolates carry the ospC gene on two different plasmids, while
the B. tuncatae isolate 91E135 carries the gene on four
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different linear plasmids. The B. turicatae RML strain has
only one plasmid carrying the gene; however, it is possible
that there could be multiple ospC-carrying plasmids of the
same size which were not resolved individually. Consistent
with the detection of multiple ospC genes by Southern blot
analysis of TAFE-fractionated DNA, multiple hybridizing
bands were also observed when DNA restricted with either

PstI, HindIII, or EcoRV was Southern blotted and probed
with the pC13 oligonucleotide (data not shown). Since only
weak hybridization of the pC13 probe was observed with B.
anserina, we could not definitively map the ospC gene in this
species. However, in B. anserina, transcript was readily
detected by both Northern blotting and primer extension
analyses with two different probes. One possible explanation
for this may be sequence divergence within the probe target
site. Since DNA-RNA hybrids are more stable than DNADNA hybrids (6a), our ability to detect transcript presumably reflects the greater level of detection sensitivity for the
DNA-RNA hybrid (6a).
Transcriptional start site analysis is a valuable approach
for assessing the control regions and regulation of a given
gene. In this report, we have employed this approach to
compare the organization of the regulatory regions of the
ospC homolog found in Borrelia species not associated with
Lyme disease with that seen in B. burgdorferi, B. gannii,
and group VS461. Previously, we have demonstrated that in
the Lyme disease spirochetes, the ospC gene is under the
control of multiple promoters (22). The transcriptional start
site analyses conducted here do not provide evidence for the
use of multiple promoters in other Borrelia species since
only one transcriptional start site was observed. While two
transcriptional start sites occur in B. anserina, they are
separated by only three nucleotides and hence are presumably derived from the same or overlapping promoters. In the
Lyme disease spirochete species, the multiple promoters do
not overlap and are separated by approximately 25 nucleotides. The ospC gene in Borrelia species not associated
with Lyme disease is driven by a promoter with spacing from
the translational start codon equivalent to that of the ospC
promoter P1 in Lyme disease spirochetes (22). All Borrelia
species and isolates that we have tested exhibit an ospC 5'
untranslated leader sequence of approximately 20 nucleotides. The size of the ospC transcript in B. henrmsii, B.
turicatae, and B. anserina (730 nucleotides) is also consistent with that reported for the Lyme disease spirochetes
(22). In contrast, B. parken and B. coniaceae exhibited ospC
transcripts that are approximately 400 nucleotides longer
than that seen in the other Borrelia species. It is not known
whether the ospC transcripts in these species possess additional coding capacity. Since the 5' untranslated leader
sequences are the same length in all isolates tested, the
additional 400 nucleotides must be contained either in the

coding sequence or 3' of the gene. While several isolates
were found by Southern blot analysis to possess more than
one copy of the homolog gene, it is not known at this time
whether all copies of the gene are complete and transcriptionally active or whether some may exist in silent loci, as
has been demonstrated for the vmp genes of B. hermsii (25).
While several isolates were found to produce ospC trannot all of those produced an apparent OspC protein.
As inferred from Northern blot analyses, the B. hernsii
isolates MAN-1 and YOR-1 both transcribed the gene at
levels more than 100-fold higher than that seen in other
isolates (excluding the Lyme disease spirochete isolates
VS102 and DN127, which served as positive controls). While
the MAN-1 isolate did exhibit an immunoreactive protein, its
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abundance as inferred from protein profile and Western blot
analysis was less than that expected on the basis of the
amount of transcript detected. Similarly, for isolate YOR-1,
only a small amount of immunoreactive protein which was of
slightly greater molecular weight than that observed in the
other species was observed. The disparity between transcript levels and amount of protein produced may be the
result of undefined posttranscriptional control mechanisms.
Similar observations concerning ospC transcript levels and
amount of protein produced have been noted for the Lyme
disease spirochetes (22). It is also possible that while there
are multiple copies of the gene, they may not all yield
translatable transcript. An analysis of the ospC gene sequences in these species should provide a further understanding of these observations. B. parkeri also exhibited a
24-kDa immunoreactive protein. On the basis of the size of
the B. parkeri OspC, the additional 400 nucleotides observed
in the ospC transcript in this isolate presumably reside 3' of
the coding sequence. An ospC transcript of 1,150 nucleotides was also observed in B. coriaceae; however, an
immunoreactive protein was not observed. After the original
submission of the manuscript for this article, it was reported
by Wilske et al. (37) that a protein which is immunoreactive
with the same OspC-directed polyclonal sera used in this
report was observed in B. hermsii HS1.
Through several approaches, we have demonstrated that a
homolog of the ospC gene originally described for Lyme
disease spirochete species (12) can also be found in other
species of the genus Borrelia. In summary, the protein
encoded by this homolog gene is immunologically reactive
with OspC-specific antisera and in most isolates is of the
same molecular weight as the OspC found in Lyme diseaseassociated species. The transcript derived from the gene is
the same size (in most isolates) and possesses a 5' untranslated leader sequence of the same length as that seen for the
ospC gene. The ospC homolog gene differs from that seen in
the Lyme disease spirochetes in that it is carried on linear
plasmids rather than on circular plasmids. The mapping of
the gene to linear plasmids provides further insight into the
coding capacity of these extrachromosomal genetic elements
in species of the genus Borrelia. The results presented here
suggest that detection of anti-OspC antibodies in suspected
Lyme disease patients may not be a reliable indicator of
infection with one of the three Lyme disease-associated

spirochete species.
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